Physician profile
Andrew Ross
NPI 1649833013
$1,886.83
in general payments reported to CMS, 2019-2025
10 companies · $582 in 2025
The $582 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $96.22 · 2022: $64.57 · 2023: $165 · 2024: $979 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $430.38 | 2024-2025 | Trumatch |
| Stryker Corporation | $359.10 | 2022-2025 | Xpress Ent Dilation System, Na, Scopis Ent |
| Integra Lifesciences Corporation | $305.08 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Regeneron Healthcare Solutions, INC. | $220.96 | 2021-2024 | |
| Genzyme Corporation | $142.62 | 2022-2024 | |
| Inspire Medical Systems, INC. | $133.80 | 2024 | Inspire |
| Zimmer Biomet Holdings, INC. | $123.22 | 2025 | Traumaone |
| Glaxosmithkline, LLC. | $122.88 | 2025 | Nucala |
| Ets Wound Care LLC | $31.82 | 2025 | Mirragen Advanced Wound Matrix |
| Genentech USA, INC. | $16.97 | 2023 | Ocrevus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.